IRIDEX Corporation
IRIX
$0.97
-$0.26-21.14%
| Weiss Ratings | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.32 | |||
| Price History | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -21.77% | |||
| 30-Day Total Return | -39.75% | |||
| 60-Day Total Return | -43.60% | |||
| 90-Day Total Return | -39.38% | |||
| Year to Date Total Return | -46.99% | |||
| 1-Year Total Return | -62.40% | |||
| 2-Year Total Return | -55.09% | |||
| 3-Year Total Return | -75.69% | |||
| 5-Year Total Return | -44.25% | |||
| 52-Week High % Change | -66.30% | |||
| 52-Week Low % Change | 6.03% | |||
| Price | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.65 | |||
| 52-Week Low Price | $1.16 | |||
| 52-Week Low Price (Date) | Mar 10, 2025 | |||
| 52-Week High Price (Date) | Apr 09, 2024 | |||
| Valuation | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 20.46M | |||
| Enterprise Value | 21.51M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.68 | |||
| Earnings Per Share Growth | 40.19% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.42 | |||
| Price/Book (Q) | 7.80 | |||
| Enterprise Value/Revenue (TTM) | 0.44 | |||
| Price | $0.97 | |||
| Enterprise Value/EBITDA (TTM) | -2.13 | |||
| Enterprise Value/EBIT | -1.98 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 16.58M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 650 940 4700 | |||
| Address | 1212 Terra Bella Avenue Mountain View, CA 94043 | |||
| Website | www.iridex.com | |||
| Country | United States | |||
| Year Founded | 1989 | |||
| Profitability | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -22.46% | |||
| Profit Margin | -22.78% | |||
| Management Effectiveness | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -20.89% | |||
| Return on Equity | -- | |||
| Income Statement | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 48.43M | |||
| Total Revenue (TTM) | 48.43M | |||
| Revenue Per Share | $2.92 | |||
| Gross Profit (TTM) | 18.80M | |||
| EBITDA (TTM) | -10.08M | |||
| EBIT (TTM) | -10.88M | |||
| Net Income (TTM) | -11.04M | |||
| Net Income Avl. to Common (TTM) | -11.04M | |||
| Total Revenue Growth (Q YOY) | -9.88% | |||
| Earnings Growth (Q YOY) | -10.21% | |||
| EPS Diluted (TTM) | -0.68 | |||
| EPS Diluted Growth (Q YOY) | -9.09% | |||
| Balance Sheet | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.86M | |||
| Cash Per Share (Q) | $0.23 | |||
| Total Current Assets (Q) | 24.34M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.62M | |||
| Current Ratio (Q) | 1.535 | |||
| Book Value Per Share (Q) | $0.16 | |||
| Total Assets (Q) | 30.15M | |||
| Total Current Liabilities (Q) | 15.85M | |||
| Total Debt (Q) | 4.91M | |||
| Total Liabilities (Q) | 27.53M | |||
| Total Common Equity (Q) | 2.62M | |||
| Cash Flow | IRIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 28.00K | |||
| Cash from Financing (TTM) | 2.87M | |||
| Net Change in Cash (TTM) | -4.12M | |||
| Levered Free Cash Flow (TTM) | -412.20K | |||
| Cash from Operations (TTM) | -7.03M | |||
